Comparison of the pharmacokinetics of verapamil in the pregnant and non-pregnant rabbit: study of maternal and foetal tissue levels

References

• BAI, S. A., LANICFORD, S. M. and JOHNSON, L. M., 1993, Pharmacokinetics of the enantiomers of verapamil in the dog. Chirality, 5, 436–442.
   PubMed Web of Science ®Google Scholar
• BYERLY, W. G., HARTMANN, A., FASTER, D. E. and TANNENBAUN, A. K., 1991, Verapamil in the treatment of maternal paroxysmal supraventricular tachycardia. Annals of Emergency Medicine, 20, 552–554.
   PubMed Web of Science ®Google Scholar
• FORT, D. J. S., LEWIS, M. J. and LUSCOIVIBE, D. K., 1992, Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers. British Journal of Clinical Pharmacokinetics, 33, 623–627.
   Google Scholar
• FRAME, L. J., 1996, Paso transplacentario y modificaciones en la cinetica del diltiazem durante la gestaciOn y la ontogenesis en el conejo. Tesis doctoral, University of Zaragoza.
   Google Scholar
• GARCIA, M. A., ARAMAYONA, J. J., BREGANTE, M. A., FRAME, L. and SOLANS, C., 1997, Simultaneous determination of verapamil and norverapamil in biological samples by high performance liquid chromatography using UV detection. Journal of Chromatography B, 693, 377–382.
   PubMedGoogle Scholar
• GIACOMINI, J. C., NELSON, W. L., THEODORE, L., WONG, F. M., ROOD, D. and GIACOMINI, K. M., 1985, The pharmacokinetics and pharmacodynamics of D- and D-L,verapamil in rabbits. Journal of Cardiovascular Pharmacology, 7, 469–475.
   PubMedGoogle Scholar
• GILLESPIE, M. N., FELDER, T. B., BLANFORD, S. L., REINSEL, C. N. and KOSTENBAUER, H. B., 1984, Pulmonary disposition and pharmacodynamics of verapamil. Journal of Cardiovascular Phar-macology, 6, 802–807.
   PubMedGoogle Scholar
• HAMANN, S. R., BLOUIN, R. A. and MCALLISTER, R. G., 1984, Clinical pharmacokinetics of verapamil. Clinical Pharmacokinetics, 9, 26–41.
   PubMed Web of Science ®Google Scholar
• HAMANN, S. R., TODD, G. D. and MCALLISTER, R. G., 1983, The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog. Pharmacology, 27, 1–8.
   PubMedGoogle Scholar
• HILDEBRANDT, R., WEITZEL, H., WARNICE, K. and GUNDERT -REMY, U., 1993, Pharmacokinetics of fenoterol in pregnant and nonpregnant women. European Journal of Clinical Pharmacology, 45, 275–277.
   Google Scholar
• IT0, S., MAGEE, L. and SMALLHORN, J., 1994, Drug therapy for fetal arrhythmias. Clinica Perinatologica, 21, 543–572.
   Google Scholar
• JEFFRIES, W. S. and BOCHNER, F., 1988, The effect of pregnancy on drug pharmacokinetics. Medical Journal of Australia, 149, 675–677.
   PubMedGoogle Scholar
• KRAUER, B. and KRAUER, F., 1983, Drug kinetics in pregnancy. In M. Gibaldi and L. Prescott (eds), Handbook of Clinical Pharmacokinetics (Balgowlah: ADIS Health Science Press), pp. 1–17.
   Google Scholar
• LOEBSTEIN, R., LALKIN, A. and KOREN, G., 1997, Pharmacokinetic changes during pregnancy and their clinical relevance. Clinical Pharmacokinetics, 33, 328–343.
   PubMed Web of Science ®Google Scholar
• MANITPISITKUL, P. and CHIOU, W. L.,1993, Intravenous verapamil kinetic in rats: marked arteriovenous concentration difference and comparison with humans. Biopharmaceutics and Drug Disposition, 14, 555–566.
   PubMedGoogle Scholar
• McTAvisu, D. and SORKIN, E. M., 1989, Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs, 38, 19–76.
   PubMedGoogle Scholar
• MITANI, G. M., STEINBERG, I., LIEN, E., HARRISON, C. and ELKAYAN, U., 1987, The pharmacokinetics of antiarrythmic agents in pregnancy and lactation. Clinical Pharmacokinetics, 12, 253-291. MURRAY, L. and SEGER, D., 1994, Drug therapy during pregnancy and lactation. Emergency Medical Clinical North America, 12, 129–149.
   Google Scholar
• O'HARE, M. F., KINNEY, C. D., MURNAGHAN, G. A. and McDEYHT, D. G., 1984, Pharmacokinetics of propranolol during pregnancy. European Journal of Clinical Pharmacology, 27, 583–587.
   Google Scholar
• ORLANDI C., MARLETTINI, M. G., CASSANI, A., TRABATTI M., AGOSTINI, D., SALOMONE, T. and TESTONI, N., 1986, Treatment of hypertension during pregnancy with the calcium antagonist verapamil. Current Therapeutics Research Clinical and Experimental, 39, 884–893.
   Google Scholar
• SZYMANSKI, W., SKUBLICKI S., JANKOWSKI, A. and KOTZBACH, R., 1992, Pharmacokinetic investigations of verapamil used an a concomitant drug in treatment of premature labor. Ginecologica. Polska, 63, 166–171.
   Google Scholar
• WARD, R. M., 1992, Maternal drug therapy for fetal disorders. Seminary Perinatology, 16, 12-20. WILSON, A. G. E., PICKETT, R. D., ELING, T. E. and ANDERSON, M. W., 1979, Studies on the persistence of basic amines in the rabbit lung. Drug Metabolism and Disposition, 76, 420–424.
   Google Scholar
• WITTER, F. R., 1993, Clinical pharmacokinetics in the treatment of rheumatoid arthritis in pregnancy. Clinical Pharmacokinetics, 25, 444–449.
   PubMedGoogle Scholar
• WOLFF, F., BREUKER, K. H., SCHLENSICER, K. H. and BOLTE, A., 1980, Prenatal diagnosis and therapy of fetal heart rate anomalies: with a contribution on the placental transfer of verapamil. Journal of Perinatal Medicine, 8, 203–208.
   PubMed Web of Science ®Google Scholar
• YAMAOKA, K., NAKAGAWA, T. and UNO, T., 1978, Application of the Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetics. Journal of Pharmacokinetics and Bio-pharmaceutics, 6, 165–175.
   PubMedGoogle Scholar